CHARACTERISTICS OF SKIN HORMONAL BALANCE REGULATION IN FEMALE MICE IN DYNAMICS OF TRANSPLANTABLE B16/F10 MELANOMA GROWTH
V. A. Bandovkina,
E. M. Frantsiyants,
I. V. Kaplieva,
M. B. Kozlova,
L. K. Trepitaki,
N. D. Cheryarina https://doi.org/10.18705/2311-4495-2017-4-3-45-53
Abstract
Background: Skin cells are capable of the local synthesis of sex and regulatory hormones which makes it an analogue of the hypothalamic-pituitary-gonadal system and facilitates independent melanoma hormonogenesis.
Aims: to study the level of hormones in the tumor, perifocal zone, the skin is unaffected, and the pituitary gland in the dynamics of growth of melanoma B16/F10 in female C57BL/6 mice.
Materials and methods: Changes in the local steroidogenesis in the dynamics of the growth of transplanted В16/F10 melanoma (from week 1 to week 4) were studied in 40 female С57BL/6 mice. Hormones were determined by standard ELISA methods and radioimmunoassay in homogenates of tumor, surrounding tissues and intact tissues.
Results: Tumor and then surrounding tissues showed an increase in estrogens, mostly due to estrone increase, with the development of relative androgen deficiency primarily in tumor and then in the perifocal zone and in intact tissues.
Conclusions: Regulation and stimulation of such changes were performed at early stages by autocrine regulatory mechanisms and cells of primary and growing melanoma, and later by the paracrine method spreading its influence on surrounding tissues and the whole body.
About the Authors
V. A. Bandovkina
Rostov Research Institute of Oncology
Russian Federation
Competing Interests:
Russian Federation
Valeriya A. Bandovkina - PhD, senior researcher of Laboratory of malignant tumor pathogenesis study.
14 line, 63, Rostov-on-Don, 344037
Competing Interests:
нет конфликта интересов
E. M. Frantsiyants
Rostov Research Institute of Oncology
Russian Federation
Competing Interests:
Russian Federation
Elena M. Frantziyants - Dr. Sci., Prof., Head of Laboratory of Malignant tumor pathogenesis.
Rostov-on-Don
Competing Interests:
нет конфликта интересов
I. V. Kaplieva
Rostov Research Institute of Oncology
Russian Federation
Competing Interests:
Russian Federation
Irina V. Kaplieva - PhD, MD, senior researcher of Laboratory of malignant tumor pathogenesis study.
Rostov-on-Don
Competing Interests:
нет конфликта интересов
M. B. Kozlova
Rostov Research Institute of Oncology
Russian Federation
Competing Interests:
Russian Federation
Irina V. Kaplieva - PhD, MD, senior researcher of Laboratory of malignant tumor pathogenesis study.
Rostov-on-Don
Competing Interests:
нет конфликта интересов
L. K. Trepitaki
Rostov Research Institute of Oncology
Russian Federation
Competing Interests:
Russian Federation
Lidiya K. Trepitaki - researcher of Laboratory of malignant tumor pathogenesis study.
Rostov-on-Don
Competing Interests:
нет конфликтов интересов
N. D. Cheryarina
Rostov Research Institute of Oncology
Russian Federation
Competing Interests:
Russian Federation
Natal’ya D. Cheryarina - laboratory doctor of Laboratory of malignant tumor pathogenesis study.
Rostov-on-Don
Competing Interests:
нет конфликтов интересов
References
1. Isola AL, Eddy K, Chen S. Biology, therapy and implications of tumor exosomes in the progression of melanoma. Cancers (Basel). 2016;8(12):110.
2. Chao C, Martin RC, Ross MI, et al. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol. 2004;11:259-264.
3. Nosrati A, Wei ML. Sex disparities in melanoma outcomes: the role of biology. Arch Biochem Biophys. 2014; 563:42-50.
4. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–3634.
5. Karagas MR, Zens MS, Stukel TA, et al. Pregnancy history and incidence in melanoma in women: a pooled analysis. Cancer Causes Control. 2006; 17:11-19.
6. Scoggins CR, Ross MI, Reintgen DS, et al. Melanoma trial gender-related differences in outcome for melanoma patients. Ann Surg. 2006; 243(5):693-700.
7. de Giorgi V, Mavilia C, Massi D, et al. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerasechain reaction and immunohistochemical study. Arch Dermatol. 2009; 145(1):30-36.
8. Slominski A. Neuroendocrine activity of the melanocyte. Exp Dermatol. 2009;18(9): 760-763.
9. Slominski AT, Zmijewski MA, Skobowiat C, et al. Sensing the environment: regulation of local and global homeostasis by the skin’s neuroendocrine system. Adv Anat Embryol Cell Biol. 2012; 212:1-115.
10. Cichorek M, Wachulska M, Stasiewicz A, Tymi´nska A. Skin melanocytes: Biology and development. Adv Dermatol Allergol. 2013;30(1):30-41.
11. Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochem Photobiol. 2008; 84:539-549.
12. Kichigina TN, Grushin VN, Belikova IS, Myadelets OD. Melanocytes: structure, function, methods of identification, role in cutaneous pathology. Vestnik VGMU. 2007;6(4):5-16. In Russian [Кичигина Т.Н., Грушин В.Н., Беликова И.С., Мяделец О.Д. Меланоциты: строение, функции, методы выявления, роль в кожной патологии. Вестник ВГМУ. 2007; 6(4):5-16.]
13. Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol. 2010; 24(11):1312-1316.
14. Bandovkina VA, Frantsiyants EM, Pogorelova YA, Cheryarina ND. Characteristics of steroidogenesis in the tumor and surrounding tissues in experimental melanoma B16. Molekulyarnaya meditsina. 2015;5:47-51. In Russian [Бандовкина В.А., Франциянц Е.М., Погорелова Ю.А., Черярина Н.Д. Особенности стероидогенеза в опухоли и окружающих тканях при экспериментальной меланоме В16. Молекулярная медицина. 2015; 5:47-51].
15. Kit OI, Frantsiyants EM, Bandovkina VA, Cheryarina ND. Growth factors vascular of endothelial and receptors in the dynamic of transplantable melanoma B16/F10 development. Rossiiskii onkologicheskii zhurnal. 2016; 21(5):253-258. In Russian [Кит О.И., Франциянц Е.М., Бандовкина В.А., Черярина Н.Д. Половые различия функционирования щитовидной железы в динамике роста перевивной меланомы В16/F10 у мышей. Российский онкологический журнал. 2016; 21(5):253-258].
16. Treshhalina EM, Zhukova OS, Gerasimova GK, Andronova NV, Garin AM The guidelines for preclinical studies of pharmaceuticals. M.: Grif i K; Ch.1. 2012: 642—657. In Russian [Трещалина Е. М., Жукова О. С., Герасимова Г. К., Андронова Н. В., Гарин А. М. Руководство по проведению доклинических исследований лекарственных средств. М.: Гриф и К; Ч.1. 2012: 642—657].
17. Leonova ZA, Florensov VV. Synthesis and functions of female sex hormones. Sibirskii meditsinskii zhurnal. 2013; 2:10-13. In Russian [Леонова З.А., Флоренсов В.В. Синтез и функции женских половых гормонов. Сибирский медицинский журнал. 2013; 2:10-13.]
18. Yur’eva OV, Dubrovina VI Role of cyclic nucleotide signal systems in regulation of immunoand pathogenesis. Byulleten’ VSNTs SO RAMN. 2012; 2(84):159-163. In Russian [Юрьева О.В., Дубровина В.И. Роль сигнальных систем циклических нуклеотидов в регуляции иммунои патогенеза. Бюллетень ВСНЦ СО РАМН. 2012; 2(84):159-163].
19. Bandovkina VA, Frantsiyants EM, Cheryarina ND, et al. Regulatory role of estrogens in activation of angiogenesis and lymphogenesis growth factors in pathogenesis of B16/ F10 melanoma. Sovremennye problemy nauki i obrazovaniya. 2015; 4. In Russian [Бандовкина В.А., Франциянц Е.М., Черярина Н.Д., и др. Регуляторная роль эстрогенов в активации факторов роста ангиои лимфогенеза в патогенезе меланомы В16/F10. Современные проблемы науки и образования. 2015; 4: URL: http://www.science-education.ru/127-20520].
Review
For citations:
Bandovkina V.A., Frantsiyants E.M., Kaplieva I.V., Kozlova M.B., Trepitaki L.K., Cheryarina N.D. CHARACTERISTICS OF SKIN HORMONAL BALANCE REGULATION IN FEMALE MICE IN DYNAMICS OF TRANSPLANTABLE B16/F10 MELANOMA GROWTH. Translational Medicine. 2017;4(3):45-53. (In Russ.) https://doi.org/10.18705/2311-4495-2017-4-3-45-53
Views:
993
Email this article 